263 related articles for article (PubMed ID: 10760371)
1. Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y(1) receptor antagonist BIBO 3304.
Kask A; Harro J
Neuropharmacology; 2000 Apr; 39(7):1292-302. PubMed ID: 10760371
[TBL] [Abstract][Full Text] [Related]
2. Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents.
Wieland HA; Engel W; Eberlein W; Rudolf K; Doods HN
Br J Pharmacol; 1998 Oct; 125(3):549-55. PubMed ID: 9806339
[TBL] [Abstract][Full Text] [Related]
3. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
Kask A; Rägo L; Harro J
Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y receptor(s) mediating feeding in the rat: characterization with antagonists.
Polidori C; Ciccocioppo R; Regoli D; Massi M
Peptides; 2000 Jan; 21(1):29-35. PubMed ID: 10704716
[TBL] [Abstract][Full Text] [Related]
5. SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine.
Masserano JM; Karoum F; Wyatt RJ
Behav Pharmacol; 1999 Jul; 10(4):429-32. PubMed ID: 10780811
[TBL] [Abstract][Full Text] [Related]
6. The NPY Y1 receptor antagonist BIBP 3226 blocks NPY induced feeding via a non-specific mechanism.
Morgan DG; Small CJ; Abusnana S; Turton M; Gunn I; Heath M; Rossi M; Goldstone AP; O'Shea D; Meeran K; Ghatei M; Smith DM; Bloom S
Regul Pept; 1998 Sep; 75-76():377-82. PubMed ID: 9802432
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of intrahippocampal NPY injection on amphetamine-induced behavioural activity.
Smiałowska M; Sopala M; Tokarski K
Neuropeptides; 1996 Feb; 30(1):67-71. PubMed ID: 8868302
[TBL] [Abstract][Full Text] [Related]
8. Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat.
Trent NL; Menard JL
Pharmacol Biochem Behav; 2011 Oct; 99(4):580-90. PubMed ID: 21693128
[TBL] [Abstract][Full Text] [Related]
9. Effects of systemic injections of dopaminergic agents on the habituation of rats submitted to an open field test.
Furlan SM; Brandão ML
Neuropsychobiology; 2001; 43(2):83-90. PubMed ID: 11174051
[TBL] [Abstract][Full Text] [Related]
10. The feeding response to melanin-concentrating hormone is attenuated by antagonism of the NPY Y(1)-receptor in the rat.
Chaffer CL; Morris MJ
Endocrinology; 2002 Jan; 143(1):191-7. PubMed ID: 11751609
[TBL] [Abstract][Full Text] [Related]
11. Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion.
Broersen LM; Feldon J; Weiner I
Neuroscience; 1999; 94(1):39-46. PubMed ID: 10613495
[TBL] [Abstract][Full Text] [Related]
12. Previous exposure to delta9-tetrahydrocannibinol enhances locomotor responding to but not self-administration of amphetamine.
Cortright JJ; Lorrain DS; Beeler JA; Tang WJ; Vezina P
J Pharmacol Exp Ther; 2011 Jun; 337(3):724-33. PubMed ID: 21389094
[TBL] [Abstract][Full Text] [Related]
13. Apomorphine-induced behavioural sensitization in rats: individual differences, role of dopamine and NMDA receptors.
Võikar V; Soosaar A; Volke V; Kõks S; Bourin M; Männistö PT; Vasar E
Eur Neuropsychopharmacol; 1999 Dec; 9(6):507-14. PubMed ID: 10625119
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
15. Repeated amphetamine administration and long-term effects on 50-kHz ultrasonic vocalizations: possible relevance to the motivational and dopamine-stimulating properties of the drug.
Simola N; Morelli M
Eur Neuropsychopharmacol; 2015 Mar; 25(3):343-55. PubMed ID: 25638025
[TBL] [Abstract][Full Text] [Related]
16. Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.
Kotagale NR; Paliwal NP; Aglawe MM; Umekar MJ; Taksande BG
Peptides; 2013 Sep; 47():7-11. PubMed ID: 23816796
[TBL] [Abstract][Full Text] [Related]
17. Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats.
van der Elst MC; Wunderink YS; Ellenbroek BA; Cools AR
Psychopharmacology (Berl); 2007 Jan; 190(1):93-102. PubMed ID: 17031706
[TBL] [Abstract][Full Text] [Related]
18. Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1 receptor selective antagonists.
Kask A; Schiöth HB; Harro J; Wikberg JE; Rägo L
Can J Physiol Pharmacol; 2000 Feb; 78(2):143-9. PubMed ID: 10737677
[TBL] [Abstract][Full Text] [Related]
19. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
Malmström RE; Balmér KC; Lundberg JM
Br J Pharmacol; 1997 Jun; 121(3):595-603. PubMed ID: 9179405
[TBL] [Abstract][Full Text] [Related]
20. Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats.
Kask A; Rägo L; Harro J
Regul Pept; 1998 Sep; 75-76():255-62. PubMed ID: 9802417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
